Exact peptide identities attached to retained registry observations carrying this condition label.
Official registry condition
Surgery peptide trials
3 selected ClinicalTrials.gov records carrying the official condition label Surgery. The label is copied from each retained registry version and does not imply that PeptideScanner has verified a diagnosis, treatment relationship, or study result.
3 selected records.
3 profiles.
2013–2026 in selected records.
Indication intelligence
Selected evidence landscape
Phase labels copied from the retained ClinicalTrials.gov versions.
Overall statuses at each retained observation, not necessarily current today.
Across the connected peptide profiles, PeptideScanner also carries 85 selected PubMed records and 50 selected Drugs@FDA applications. Those records are profile context only; PeptideScanner does not claim they concern Surgery unless their own cited source says so.
Collection change ledger
Recently changed records on this condition hub
These events come only from the exact registry records shown on this page. The condition label does not establish a diagnosis, treatment relationship, or scientific agreement.
ClinicalTrials.gov record NCT06337838
PeptideScanner retained ClinicalTrials.gov record NCT06337838 at 2026-11-16T01:33:21.554Z. Its registry update date was 2026-05-22, and PeptideScanner's reviewed identity mapping was desmopressin.
- PeptideScanner change date
- November 16, 2026
- Cited source date
- May 22, 2026
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT00223704
PeptideScanner retained ClinicalTrials.gov record NCT00223704 at 2026-11-15T22:04:12.435Z. Its registry update date was 2013-11-25, and PeptideScanner's reviewed identity mapping was icatibant.
- PeptideScanner change date
- November 15, 2026
- Cited source date
- November 25, 2013
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT02527993
PeptideScanner retained ClinicalTrials.gov record NCT02527993 at 2026-11-15T22:05:38.400Z. Its registry update date was 2018-03-07, and PeptideScanner's reviewed identity mapping was pasireotide.
- PeptideScanner change date
- November 15, 2026
- Cited source date
- March 7, 2018
- Evidence lane
- Clinical trials
Attributed registry records
Selected records
Desmopressin · 2026-05-22
ClinicalTrials.gov record NCT06337838
Recruiting at the retained observation.
Open attributed record →Pasireotide · 2018-03-07
ClinicalTrials.gov record NCT02527993
Completed at the retained observation.
Open attributed record →Icatibant · 2013-11-25
ClinicalTrials.gov record NCT00223704
Completed at the retained observation.
Open attributed record →